Effect of octreotide on experimental corneal neovascularization

Acta Ophthalmologica Scandinavica

Volumn 77, Issue 4, 1999, Pages 386-390

  Demir, Tamer ^a,b   Çeliker, Ülkü O ^a   Kükner, Aysel ^a   Mogulkoç, Rasim ^a   Çelebi, Serdal ^a   Çeliker, Hüseyin ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Corneal neovascularization; Inflammation; Octreotide; Rat

Indexed keywords

OCTREOTIDE; SILVER NITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUTERIZATION; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; FEMALE; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SLIT LAMP; STATISTICAL ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032804314     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.1999.770404.x     Document Type: Article

References (35)

1. Adamis AP, Meklir B & Joyce NC (1991): In situ injury induced release of basic fibroblast growth factor from corneal epithelial cells. Am J Pathol 139: 963-968.
2. Avery Robert L, Connor TB & Farazdaghi M (1990): Systemic amiloride inhibits experimentally induced neovascularization. Arch Opht 108: 1474-1476.
3. Baudoin C, Reygrobellet DF & Caruelle JP (1990): Acidic fibroblast growth factor distribution in normal human eye and possible implications in ocular pathogenesis. Opthalmic Res 22: 73-81.
4. Belin MW, Bouchard CS, Frantz S & Chmielinska J (1989): Topical cyclosporine in high risk corneal transplants. Ophthalmology 96: 1144-1150.
5. Cool DE, Andreassen PR, Tonks NK, Krebs EG, Fischer EH & Morgolis RL (1992): Cytokinetic failure and asynchronous nuclear division in BHK cells overexpressing a truncated protein-tyrosine-phoshates. Proc Natl Acad Sci USA 89: 5422-5426.
6. Folkman J, Klagsburn M, Sasse J, et al. (1998): A heparin-binding angiogenic protein- basic fibroblast growth factor is stored within basement membrane. Am J Pathol 130: 393-399.
7. Grant MB, Wargovich TJ, Ellis EA, Caballero BS, Mansour M & Pepine CJ (1994): Localization of insulin-like growt factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. Circulation 89: 1511-1517.
8. Granzyna M, Niederkon K & Niederkon JY (1993): Spontaneous corneal neovascularization in nude mice. Invest Ophthalmol Vis Sci 31: 222-230.
9. Günal AI, Işik A, Çeliker H & Eren O (1996): Short term reduction of left ventricular mass in primary hypertrophic cardiomyopathy by octreotide injections. Heart 76: 418-421.
10. Jeanny JC, Fayein N, Moenner M, et al. (1987): Spesific fixation of bovine brain and retinal acidic and basic fibroblast growth factor to mouse embryonic eye basement membrane. Exp Cell Res 171: 63-67.
11. Kinoshita S & Manabe R (1992): Chemical burns. In: Brightbill FS, editor. Corneal Surgery. 316-317. St Louise: Mosby Year-Book.
12. Klijn JGM, Setyono-Han B, Bakker GH, Wonderburg MEL & Bontenbal M (1990): Growth factor receptor pathway interfering treatment by somatostatin analoques and suramin: Pre clinical and clinical studies. J Steroid Biochem Molec Biol 37: 1089-1095.
13. Kurg AW, Michon J, Tai KS & Chan FL (1996): The effect of somatostatin versus corticosteroid in the treatment of Graves' ophthalmopaty. Tyroid 6: 381-384.
14. Lamberts SW (1988): The role of somatostatin in regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr Rev 9: 417-436.
15. Leibovitch SJ, Polverini PJ & Shepard HM (1987): Macrophage induced angiogenesis mediated by tumor necrosis factor - alpha. Nature 329: 630-637.
16. Leibowitz HM, Morello S, Stern M & Kupferman A (1990): Effect of topically administered epidermal growth factor on corneal wound strength. Arch Ophthalmol 108: 734-737.
17. Luo Q, Peyman GA, Conway MD & Weltering EA (1996): Effect of a somatostatin analoge (octreotide acetate) on the growth of retinal pigment epithelial cells in culture. Curr Eye Res 15: 909-913.
18. Lutty GA, Thompson DC, Gallup JY, et al. (1983): Vitreus: An inhibitor of retinal extract-induced neovascularization. Invest Ophthalmol Vis Sci 24: 52-57.
19. Mahoney J & Waterbury LD (1985): Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea. Eye Res 4: 531-535.
20. Mallet B, Vialettes B, Haroche S, Escoffier P, Gastaut P, Taubert JP & Vauge P (1992): Stabilization of severe proliferative diabetic retinopathy by long term treatment with SMS 201-995. Diabet Metab 18: 438-444.
21. Mun EC, Doctrow SR, Carter R, et al. (1989): An angiogenesis inhibitor from the cornea. Invest Ophthalmol Vis Sci 30: 151-155.
22. Nirankari US, Dandona L & Rodrigues MM (1994): Laser photocoagulation experimental corneal stromal vascularization. Ophthalmol 100: 111-118.
23. Parmar H, Bogden A, Mollard M, de Rouge B, Phillips RH & Lightman SL (1989): Somatostatin and somatostatin anologues in oncology. Cancer Treat Rev 16: 95-115.
24. Pepose JS & Ubels JL (1992): The cornea. In: Hart MW, editor. Adler's Physiology of the Eye. 3:29-70. Missouri, Westline Industrial Drive.
25. Reygrobellet FD, Boudouin C, Negre F, Caruelle JP & Gastaud P (1991): Acidic FGF and other growth factors in preretinal membranes from patiens with diabetic retinopathy and proliferative vitreoretinopathy. Opthalmic Res 23: 154-161.
26. Richard C, William W & Anthony PA (1994): Ocular angiogenesis. In: Albert MD, Jacobiec AF (eds). Principles and Practice of Ophthalmology Basic Sciences. 94: 1100-1106. Philadelphia, The Curtis Center.
27. Satoh T, Kan M, Masuko K & Obinata M (1989): Characterization of a new endothelial cell growth factor (f-ECGF) partially purified from the supernatant of human fibroblast cells. Biol Cell Jpn Soc 14: 731-740.
28. Scott K, Muegge D & Muegge K (1995): Cytokines linking the immune and inflammatory systems: IL-1, TNF, IL-6, IFN-ab and TGF-b. In: Robert RR, Fleisher TA, Schwartz BD (eds). Clinical Immunology Principles and Pratice 23: 350-362. UK.
29. Seymour R (1985): Neuroendocrinology. 492-567. Washington, WB Saunders Company.
30. Shumak SL, Grossman LD, Chew E, Kozousek V, George SR, Singer W, et al. (1990): Growth hormone suppression and nonproliferative diabetic retinopathy; a preliminary feasibility study. Clin Invest Med 13: 287-292.
31. Terranova PV, Diflorio R, Lyall MR, Hic S, Friesel R & Maciag T (1985): Human endothelial cells are chemotactic to endothelial cell growth factor and heparin. J Cell Biol 10: 2330-2334.
32. Timothy W, Olsen MD, Nancy M, Benegas MD, Andrea C, Joplin MD, et al. (1994): Rapamycin inhibits corneal allograft rejection and neovascularization. Arch Ophthalmol 112: 1471-1475.
33. Tripathi B, Kwait P & Tripathi R (1989): Corneal growth factors a new generations of ophthalmic pharmaceuticals. Cornea 9: 2-9.
34. Yarden Y & Ullrich A (1988): Growth factor receptor tyrosine kinases. Annu Rev Biochem 57: 443-478.
35. Yogesh C, Murthy KK & Escher EE (1990): Mechanism of action of somatostatin. An overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins. Metabolism 39: 63-69.